Skip to main content

Alphatec Holdings(ATEC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low12.35
Day High12.71
Open:12.56
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Alphatec Holdings

Select a category then submit the form to load news
Tipranks
Barclays Sticks to Their Buy Rating for Alphatec Holdings (ATEC)
Tipranks
Alphatec Holdings Announces Board Director Retirement and Changes
Tipranks
Alphatec Earnings Call Highlights Growth And Margins
Tipranks
Lake Street Sticks to Its Buy Rating for Alphatec Holdings (ATEC)
Tipranks
Stifel Nicolaus Sticks to Its Buy Rating for Alphatec Holdings (ATEC)
Tipranks
Canaccord Genuity Remains a Buy on Alphatec Holdings (ATEC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and Alphatec Holdings (ATEC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardiff Oncology (CRDF) and Alphatec Holdings (ATEC)
Motley Fool
ACM Research’s AI Surge Collides With Export Controls and Chip Spending Cycles
Motley Fool
Alphatec (ATEC) Q4 2025 Earnings Call Transcript
Tipranks
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Viridian Therapeutics (VRDN) and Enovis (ENOV)
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Alphatec Holdings (ATEC) and Hyperfine (HYPR)
Tipranks
Lake Street Keeps Their Buy Rating on Alphatec Holdings (ATEC)
Tipranks
Alphatec Holdings (ATEC) Gets a Buy from Wells Fargo
Motley Fool
EVP People and Culture Sells ATEC 33K Shares for $679K
Tipranks
Canaccord Genuity Remains a Buy on Alphatec Holdings (ATEC)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alphatec Holdings (ATEC), Biohaven Ltd. (BHVN) and Syndax Pharmaceuticals (SNDX)
Tipranks
TD Cowen Sticks to Their Buy Rating for Alphatec Holdings (ATEC)
Motley Fool
Alphatec Stock Up 126% as CEO Sells $2 Million in Shares -- Here's What Investors Should Know
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alphatec Holdings (ATEC) and EyePoint Pharmaceuticals (EYPT)
Motley Fool
Is Alphatec Stock a Buy or Sell After Its COO Dumped Nearly 20,000 Shares?
Tipranks
Alphatec Holdings (ATEC) Gets a Buy from Canaccord Genuity
Tipranks
Alphatec Holdings (ATEC) Receives a Buy from Wells Fargo
Tipranks
Alphatec Holdings (ATEC) Receives a New Rating from Freedom Capital Markets
Motley Fool
Alphatec Executive Unloads 100,000 Shares for $2 Million on Earnings Beat
Motley Fool
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45%
Motley Fool
Why This Private Equity-Style Fund Just Bet $17 Million on Lumen Technologies Stock
Motley Fool
Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge
Motley Fool
Penn Capital Dumps Entire Chart Industries Stake
Tipranks
Alphatec Holdings Mourns Loss of Board Member
Business Wire
ATEC Mourns Passing of Board Member Jeffrey P. Rydin

Profile

Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company's principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.